FeesSafety
Pluang+

LKQ shares plunge 22% after CEO exit and ERP system issues shake investor confidence

Market News
27 Oct 2026, 01:31 WIB
GlobeNewsWire
View Source
Bearish
LKQ shares plunge 22% after CEO exit and ERP system issues shake investor confidence

LKQ Corporation's shares dropped 22% following the sudden departure of CEO Justin Jude and ongoing problems with its ERP system in Europe, which severely impacted profitability. The company reported a net loss of $16 million in Q3 2026, down from a $79 million profit the previous quarter, largely due to operational disruptions in Europe. This has wiped out over $2.2 billion in market value since July, prompting an investor rights firm to investigate whether LKQ was transparent about the ERP issues. Investors are urged to report losses and provide information to support the investigation.

LKQ Corporation's recent challenges are noted here with Pluang's market data as of Oct 27, 2026 04:21 WIB. For readers following Consumer Cyclical-sector US stocks, 70 of 134 stocks rose while 63 fell. Notable movers include MELI at USD 1,669.54 with a 1-day change of -7.77% and a Pluang order activity of 36% Sell / 64% Buy, HOG at USD 29.11 up 6.47%, and BBY at USD 99.78 up 6.01% with a Pluang order activity of 99% Sell / 1% Buy. The most notable figure is MELI's 1-day change of -7.77%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App